Lipo-4MA (AntiCancer Inc)

N/A

Report date: 2025/01/26 18:01:24
NME

Base Information

Drug NameLipo-4MA (AntiCancer Inc)
Drug Alias Nameliposomal 5a-reductase inhibitor( AntiCancer Inc)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 5 alpha reductase inhibitors
TargetsSteroid 5 alpha reductase
Therapy Area/IndicationsChemotherapy-induced alopeciaAcne Vulgaris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnticancer Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnticancer Inc
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced alopeciaAcne Vulgaris
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A